Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - Springer
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - europepmc.org
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi… - Cancer …, 2017 - augusta.elsevierpure.com
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi… - Cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

[引用][C] Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - cir.nii.ac.jp
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor
immunity at a mouse tumor site | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - infona.pl
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

[HTML][HTML] Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - ncbi.nlm.nih.gov
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.

T Ohkuri, A Kosaka, K Ishibashi… - Cancer Immunology …, 2017 - search.ebscohost.com
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

[PDF][PDF] Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunol …, 2017 - bioline.ru
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

T Ohkuri, A Kosaka, K Ishibashi… - Cancer Immunology …, 2017 - search.proquest.com
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by
inducing type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the …